Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats

Mark D. Lindner, Chris K. Cain, Melissa A. Plone, Beata R. Frydel, Thomas J. Blaney, Dwaine F. Emerich, Michael R. Hoane

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

The present study was conducted to determine if the full array of parkinsonian symptoms could be detected in rats with nigrostriatal cell loss and striatal dopamine depletions similar to levels reported in the clinical setting, and to determine if older rats exhibit more robust parkinsonian deficits than younger rats. Young (2 months old) and middle-aged (12 months old) rats received bilateral striatal infusions of 6-OHDA, over the next 3 months they were assessed with a battery of behavioral tests, and then dopaminergic nigrostriatal cells and striatal dopamine and DOPAC levels were quantified. The results of the present study suggest that: (1) the full array of parkinsonian symptoms (i.e. akinesia, rigidity, tremor and visuospatial cognitive deficits) can be quantified in rats with incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine levels (2) parkinsonian symptoms were more evident in middle-aged rats with 6-OHDA infusions, and (3) there was evidence of substantial neuroplasticity in the older rats, but regardless of the age of the animal, endogenous compensatory mechanisms were unable to maintain striatal dopamine levels after rapid, lesion-induced nigrostriatal cell loss. These results suggest that using older rats with nigrostriatal dopaminergic cell loss and reductions in striatal dopamine levels similar to those in the clinical condition, and measuring behavioral deficits analogous to parkinsonian symptoms, might increase the predictive validity of pre-clinical rodent models.

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalBehavioural Brain Research
Volume102
Issue number1-2
DOIs
StatePublished - Jul 1 1999

Fingerprint

Corpus Striatum
Tremor
Dopamine
Oxidopamine
3,4-Dihydroxyphenylacetic Acid
Neuronal Plasticity
Rodentia

Keywords

  • 6-OHDA
  • Age
  • Nigrostriatal cell counts
  • Parkinsonian symptoms
  • Partial lesions

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats. / Lindner, Mark D.; Cain, Chris K.; Plone, Melissa A.; Frydel, Beata R.; Blaney, Thomas J.; Emerich, Dwaine F.; Hoane, Michael R.

In: Behavioural Brain Research, Vol. 102, No. 1-2, 01.07.1999, p. 1-16.

Research output: Contribution to journalArticle

Lindner, Mark D. ; Cain, Chris K. ; Plone, Melissa A. ; Frydel, Beata R. ; Blaney, Thomas J. ; Emerich, Dwaine F. ; Hoane, Michael R. / Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats. In: Behavioural Brain Research. 1999 ; Vol. 102, No. 1-2. pp. 1-16.
@article{3e086ea28ac64fe380e76d29325d0fc6,
title = "Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats",
abstract = "The present study was conducted to determine if the full array of parkinsonian symptoms could be detected in rats with nigrostriatal cell loss and striatal dopamine depletions similar to levels reported in the clinical setting, and to determine if older rats exhibit more robust parkinsonian deficits than younger rats. Young (2 months old) and middle-aged (12 months old) rats received bilateral striatal infusions of 6-OHDA, over the next 3 months they were assessed with a battery of behavioral tests, and then dopaminergic nigrostriatal cells and striatal dopamine and DOPAC levels were quantified. The results of the present study suggest that: (1) the full array of parkinsonian symptoms (i.e. akinesia, rigidity, tremor and visuospatial cognitive deficits) can be quantified in rats with incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine levels (2) parkinsonian symptoms were more evident in middle-aged rats with 6-OHDA infusions, and (3) there was evidence of substantial neuroplasticity in the older rats, but regardless of the age of the animal, endogenous compensatory mechanisms were unable to maintain striatal dopamine levels after rapid, lesion-induced nigrostriatal cell loss. These results suggest that using older rats with nigrostriatal dopaminergic cell loss and reductions in striatal dopamine levels similar to those in the clinical condition, and measuring behavioral deficits analogous to parkinsonian symptoms, might increase the predictive validity of pre-clinical rodent models.",
keywords = "6-OHDA, Age, Nigrostriatal cell counts, Parkinsonian symptoms, Partial lesions",
author = "Lindner, {Mark D.} and Cain, {Chris K.} and Plone, {Melissa A.} and Frydel, {Beata R.} and Blaney, {Thomas J.} and Emerich, {Dwaine F.} and Hoane, {Michael R.}",
year = "1999",
month = "7",
day = "1",
doi = "10.1016/S0166-4328(98)00160-0",
language = "English (US)",
volume = "102",
pages = "1--16",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats

AU - Lindner, Mark D.

AU - Cain, Chris K.

AU - Plone, Melissa A.

AU - Frydel, Beata R.

AU - Blaney, Thomas J.

AU - Emerich, Dwaine F.

AU - Hoane, Michael R.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - The present study was conducted to determine if the full array of parkinsonian symptoms could be detected in rats with nigrostriatal cell loss and striatal dopamine depletions similar to levels reported in the clinical setting, and to determine if older rats exhibit more robust parkinsonian deficits than younger rats. Young (2 months old) and middle-aged (12 months old) rats received bilateral striatal infusions of 6-OHDA, over the next 3 months they were assessed with a battery of behavioral tests, and then dopaminergic nigrostriatal cells and striatal dopamine and DOPAC levels were quantified. The results of the present study suggest that: (1) the full array of parkinsonian symptoms (i.e. akinesia, rigidity, tremor and visuospatial cognitive deficits) can be quantified in rats with incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine levels (2) parkinsonian symptoms were more evident in middle-aged rats with 6-OHDA infusions, and (3) there was evidence of substantial neuroplasticity in the older rats, but regardless of the age of the animal, endogenous compensatory mechanisms were unable to maintain striatal dopamine levels after rapid, lesion-induced nigrostriatal cell loss. These results suggest that using older rats with nigrostriatal dopaminergic cell loss and reductions in striatal dopamine levels similar to those in the clinical condition, and measuring behavioral deficits analogous to parkinsonian symptoms, might increase the predictive validity of pre-clinical rodent models.

AB - The present study was conducted to determine if the full array of parkinsonian symptoms could be detected in rats with nigrostriatal cell loss and striatal dopamine depletions similar to levels reported in the clinical setting, and to determine if older rats exhibit more robust parkinsonian deficits than younger rats. Young (2 months old) and middle-aged (12 months old) rats received bilateral striatal infusions of 6-OHDA, over the next 3 months they were assessed with a battery of behavioral tests, and then dopaminergic nigrostriatal cells and striatal dopamine and DOPAC levels were quantified. The results of the present study suggest that: (1) the full array of parkinsonian symptoms (i.e. akinesia, rigidity, tremor and visuospatial cognitive deficits) can be quantified in rats with incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine levels (2) parkinsonian symptoms were more evident in middle-aged rats with 6-OHDA infusions, and (3) there was evidence of substantial neuroplasticity in the older rats, but regardless of the age of the animal, endogenous compensatory mechanisms were unable to maintain striatal dopamine levels after rapid, lesion-induced nigrostriatal cell loss. These results suggest that using older rats with nigrostriatal dopaminergic cell loss and reductions in striatal dopamine levels similar to those in the clinical condition, and measuring behavioral deficits analogous to parkinsonian symptoms, might increase the predictive validity of pre-clinical rodent models.

KW - 6-OHDA

KW - Age

KW - Nigrostriatal cell counts

KW - Parkinsonian symptoms

KW - Partial lesions

UR - http://www.scopus.com/inward/record.url?scp=0033049711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033049711&partnerID=8YFLogxK

U2 - 10.1016/S0166-4328(98)00160-0

DO - 10.1016/S0166-4328(98)00160-0

M3 - Article

C2 - 10403011

AN - SCOPUS:0033049711

VL - 102

SP - 1

EP - 16

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1-2

ER -